Valproate sodium description: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi (talk | contribs) (Created page with "__NOTOC__ {{Valproate sodium}} {{CMG}} ==Title== <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = DEPACON (VALPROATE SODIUM) INJECTION [ABBVIE IN...") |
Gerald Chi (talk | contribs) mNo edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}} | {{CMG}} | ||
== | ==Description== | ||
Depacon (valproate sodium) is the sodium salt of valproic acid designated as sodium 2-propylpentanoate. Valproate sodium has the following structure: | |||
<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = DEPACON (VALPROATE SODIUM) INJECTION [ABBVIE INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=da030cbb-40f6-4805-9883-0d8945afbcc3#section-1 | publisher = | date = | accessdate = }}</ref> | {| | ||
| [[File:Vs04.png|800px|thumb]] | |||
|} | |||
Valproate sodium has a molecular weight of 166.2. It occurs as an essentially white and odorless, crystalline, deliquescent powder. | |||
Depacon solution is available in 5 mL single-dose vials for intravenous injection. Each mL contains valproate sodium equivalent to 100 mg valproic acid, edetate disodium 0.40 mg, and water for injection to volume. The pH is adjusted to 7.6 with sodium hydroxide and/or hydrochloric acid. The solution is clear and colorless.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = DEPACON (VALPROATE SODIUM) INJECTION [ABBVIE INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=da030cbb-40f6-4805-9883-0d8945afbcc3#section-1 | publisher = | date = | accessdate = }}</ref> | |||
==References== | ==References== | ||
Latest revision as of 20:48, 6 February 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Description
Depacon (valproate sodium) is the sodium salt of valproic acid designated as sodium 2-propylpentanoate. Valproate sodium has the following structure:
 |
Valproate sodium has a molecular weight of 166.2. It occurs as an essentially white and odorless, crystalline, deliquescent powder.
Depacon solution is available in 5 mL single-dose vials for intravenous injection. Each mL contains valproate sodium equivalent to 100 mg valproic acid, edetate disodium 0.40 mg, and water for injection to volume. The pH is adjusted to 7.6 with sodium hydroxide and/or hydrochloric acid. The solution is clear and colorless.[1]
References
Adapted from the FDA Package Insert.